EGFR and neoplasm: Myeloid-specific deletion of EGFR in mice resulted in fewer and smaller tumours in both APCmin/+ and AOM/DSS models, and EGFR expression in myeloid cells but not in intestinal epithelial cells was associated with tumour metastasis and shorter patient survival time (66).